TipRanks
Starling Oncology Institute (STLN)
NASDAQ:STLN
US Market
STLN
Starling Oncology Institute
RESEARCH TOOLSreports
Want to see STLN full AI Analyst Report?

Starling Oncology Institute (STLN) Income Statement

210 Followers

Starling Oncology Institute Income Statement

Last quarter (Q2 2026), Starling Oncology Institute's total revenue was $161.28M, an increase of 34.62% from the same quarter last year. In Q2, Starling Oncology Institute's net income was $-9.79M. See Starling Oncology Institute’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 502.73M$ 393.41M$ 324.24M$ 252.48M$ 203.00M
Gross Profit
$ 76.44M$ 54.00M$ 59.57M$ 52.09M$ 40.85M
Operating Expenses
$ 112.52M$ 114.11M$ 136.59M$ 134.04M$ 86.71M
Depreciation and Amortization
$ 6.94M$ 6.29M$ 5.87M$ 4.41M$ 3.34M
EBITDA
$ -42.52M$ -50.88M$ -54.28M$ -67.60M$ -42.04M
Operating Income
$ -36.08M$ -60.12M$ -77.02M$ -81.95M$ -45.86M
Other Income/Expenses
$ -24.65M$ -4.54M$ -6.09M$ 81.86M$ 34.26M
Pretax Income
$ -60.74M$ -64.66M$ -83.10M$ -91.00K$ -11.60M
Net Income
$ -60.61M$ -64.66M$ -83.07M$ 152.00K$ -10.93M
Per Share Metrics
Basic EPS
$ -0.54$ -0.71$ -0.92$ 0.00$ -0.16
Diluted EPS
$ -0.54$ -0.71$ -0.92$ -0.21$ -0.16
Weighted Average Shares Outstanding
 92.39M 75.04M 73.75M 72.79M 66.23M
Weighted Average Shares Outstanding (Diluted)
 92.39M 75.04M 73.75M 80.61M 66.23M
Currency in USD

Starling Oncology Institute Earnings and Revenue History